A new polycyclic compound, 1,1′-{1,4-phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1H-pyrazole-5,1-diyl]}dibutan-1-one (3) has been synthesized by cyclocondensation of (2E,2′E)-1,1′-bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3′-(1,4-phenylene)diprop-2-en-1-one (2) and hydrazine hydrate in butanoic acid. The structure of this compound was established by elemental analysis, 1 H-NMR, 13 C-NMR, mass and IR spectroscopy.
Introduction
Quinoline nucleus is an important pharmacophore found in a large number of natural products and synthetic compounds with a wide range of applications. Indeed quinoline derivatives are some of the oldest compounds which have been utilized for the treatment of a variety of diseases; the bark of Cinchona plants containing quinine has been utilized to treat palpitations [1] . Compounds containing quinoline motif are most widely used as antimalarials [2] , antibacterials [3] , antifungals [4] and anticancer agents [5] . On the other hand, the pyrazoline moiety is an important nitrogen-containing 5-membered heterocyclic compound and various synthetic methods for their preparation have been reported [6] . Numerous pyrazoline derivatives have been found to possess considerable biological activities, which has stimulated the research activity in this field. They have several prominent effects, such as antimicrobial [7] , antimycobacterial [8] , anti-inflammatory, analgesic [9] and antiamoebic activity [10] . 2-Pyrazolines seem to be the most frequently studied pyrazoline type compounds. As a result, a large number of 2-pyrazolines using different synthetic methods for their preparation have been described in the chemistry literature. An especially popular procedure is based on the reaction of α,β-unsaturated ketones with hydrazines [11] [12] [13] . The coupling of this chemical entity with a quinoline unit might be considered to have some biological activities. Here we are reporting a novel bis[3-(quinol-3-yl)pyrazoline] prepared by cyclocondensation of the known (2E,2′E)-1,1′-bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3′-(1,4-phenylene)diprop-2-en-1-one (2) in presence of hydrazine hydrate (Scheme 1).
Experimental Section

General Methods
The starting materials were generally used as received (Acros, Fontenay-sous-Bois, France) without any further purification. Melting points were determined on an electrothermal capillary fine-control apparatus and are uncorrected. All IR spectra were performed on Shimadzu FT-IR-8201 PC spectrophotometer (Constantine, Algeria) and only significant absorption-band frequency is cited. 1 H-NMR and 13 C-NMR spectra were recorded in deuterated chloroform on a Brüker Avance DPX 250 spectrometer (Constantine, Algeria) at 250 MHz for proton and at 62.9 MHz for 13 C. Chemical shifts are given in ppm and J values in Hertz (Hz). The mass spectrum was scanned on a Shimadzu GCMS-QP2010 and the elemental analysis was obtained using a LECO CHNS-900 elemental analyzer (Lyon, France) and the values are within ±0.4% of the theoretical values.
3-Acetyl-6-chloro-2-methyl-4-phenylquinoline (1) has been synthesized in accordance with established methods [14] . Spectroscopic results and physical properties are in agreement with literature reports [15, 16] . 
Synthesis of 1,1′-{1,4-phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1H-pyrazole-5,1-diyl]}dibutan-1-one (3)
A solution of 3-acetyl-6-chloro-2-methyl-4-phenylquinoline (2.00 g, 6.7682 mmol, 2 eq.) and terephthalaldehyde (0.4568 g, 3.3841 mmol, 1 eq.) in an ethanolic solution of NaOH 10% (1.0 g in 10 mL of ethanol) was stirred for 8 h at room temperature. The solution was poured into ice cold water and solution was adjusted to pH ~ 2 by HCl (1 N). The solid was separated off and then dissolved in CH2Cl2. The organic layer was washed with a saturated solution of NaHCO3 and the solvent was evaporated to dryness. The residue was recrystallized from ethyl acetate/petroleum ether (1/1) solution to give the intermediate compound (2), m.p.: ˃300 °C, yield: 75%. Compound 2 is known in literature [17] and its structure has been confirmed by spectroscopic methods. Next, the title compound Copies of these spectra should be provided in the Supplementary Materials.
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